These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22650237)

  • 1. Pharmaceutical structure montages as catalysts for design and discovery.
    Njarðarson JT
    Future Med Chem; 2012 May; 4(8):951-4. PubMed ID: 22650237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
    Ilardi EA; Vitaku E; Njardarson JT
    J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors.
    Leung CH; Chan DS; Kwan MH; Cheng Z; Wong CY; Zhu GY; Fong WF; Ma DL
    ChemMedChem; 2011 May; 6(5):765-8. PubMed ID: 21365767
    [No Abstract]   [Full Text] [Related]  

  • 4. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC; Reymond JL
    J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in action.
    Eggert US; Superti-Furga G
    Nat Chem Biol; 2008 Jan; 4(1):7-11. PubMed ID: 18084271
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
    Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
    J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

  • 9. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
    Torre BG; Albericio F
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallographic fragment screening.
    Badger J
    Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent drug approvals from the US FDA and EMEA: what the future holds.
    Pevarello P
    Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning from PAINful lessons.
    Erlanson DA
    J Med Chem; 2015 Mar; 58(5):2088-90. PubMed ID: 25710486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graph mining: procedure, application to drug discovery and recent advances.
    Takigawa I; Mamitsuka H
    Drug Discov Today; 2013 Jan; 18(1-2):50-7. PubMed ID: 22889967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is computer-assisted rescaffolding the future in lead generation?
    Hessler G; Baringhaus KH
    Future Med Chem; 2013 Mar; 5(3):237-9. PubMed ID: 23464513
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists.
    Raveglia LF; Giardina GA
    Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990
    [No Abstract]   [Full Text] [Related]  

  • 20. Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space.
    Rabal O; Oyarzabal J
    J Chem Inf Model; 2012 May; 52(5):1086-102. PubMed ID: 22486368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.